|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
107.97(B) |
Last
Volume: |
3,217,222 |
Avg
Vol: |
8,418,111 |
52
Week Range: |
$48.64 - $75.67 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
312,036 |
508,687 |
1,007,678 |
2,119,191 |
Total Sell Value |
$23,117,519 |
$34,902,586 |
$61,221,104 |
$110,722,184 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
14 |
27 |
44 |
79 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Carruthers Wendy |
SVP, Human Resources |
|
2013-02-28 |
4 |
D |
$7.39 |
$6,732 |
D/D |
(911) |
44,159 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,793 |
45,070 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-02-28 |
4 |
D |
$7.39 |
$13,871 |
D/D |
(1,877) |
111,690 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,586 |
113,567 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-02-28 |
4 |
D |
$7.39 |
$11,780 |
D/D |
(1,594) |
81,802 |
|
- |
|
Dawkins Keith D |
EVP, Global Chief Med. Off. |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,888 |
83,396 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2013-02-28 |
4 |
D |
$7.39 |
$8,668 |
D/D |
(1,173) |
93,724 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,491 |
94,897 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2013-02-28 |
4 |
D |
$7.39 |
$6,156 |
D/D |
(833) |
76,288 |
|
- |
|
Nanavaty Maulik |
SVP & Pres, Neuromodulation |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,269 |
77,121 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-02-28 |
4 |
D |
$7.39 |
$25,237 |
D/D |
(3,415) |
129,205 |
|
- |
|
Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
132,620 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2013-02-28 |
4 |
D |
$7.39 |
$20,189 |
D/D |
(2,732) |
81,812 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,379 |
84,544 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2013-02-28 |
4 |
D |
$7.39 |
$26,013 |
D/D |
(3,520) |
132,634 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,474 |
136,154 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2013-02-28 |
4 |
D |
$7.39 |
$10,405 |
D/D |
(1,408) |
86,974 |
|
- |
|
Lance Jean Fitterer |
SVP & Chief Compliance Officer |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,190 |
88,382 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2013-02-28 |
4 |
D |
$7.39 |
$8,417 |
D/D |
(1,139) |
25,443 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,491 |
26,582 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2013-02-28 |
4 |
D |
$7.39 |
$17,706 |
D/D |
(2,396) |
71,830 |
|
- |
|
Onuscheck John Michael |
SVP & President, EMEA |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,237 |
74,226 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-02-28 |
4 |
D |
$7.39 |
$10,405 |
D/D |
(1,408) |
73,898 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,190 |
75,306 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2013-02-27 |
4 |
D |
$7.33 |
$10,826 |
D/D |
(1,477) |
42,277 |
|
- |
|
1822 Records found
|
|
Page 10 of 73 |
|
|